# Petmed Express Inc: Form 10-Q for the period ended Jun 30, 2017

- Company: [Petmed Express Inc](/companies/pets.md) (CIK 1040130)
- Form: 10-Q
- Filed: 2017-07-31
- Accepted by EDGAR: Jul 31, 2017, 13:01 ET
- Period: 2017-06-30
- Accession: 0001437749-17-013354
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1040130/000143774917013354/pets20170630_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1040130/000143774917013354/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Gross profit | 3 months, 2017-04-01 to 2017-06-30 | $27.5m | us-gaap:GrossProfit |
| Operating income | 3 months, 2017-04-01 to 2017-06-30 | $14.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2017-04-01 to 2017-06-30 | $5.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-04-01 to 2017-06-30 | $9.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2017-04-01 to 2017-06-30 | $0.45 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-04-01 to 2017-06-30 | $0.46 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-04-01 to 2017-06-30 | 20,448,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 3 months, 2017-04-01 to 2017-06-30 | $43.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2017-04-01 to 2017-06-30 | $4.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2017-06-30 | $68.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-06-30 | $95.1m | us-gaap:AssetsCurrent |
| Total assets | at 2017-06-30 | $125.7m | us-gaap:Assets |
| Current liabilities | at 2017-06-30 | $25.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-06-30 | $26.6m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-06-30 | $99.0m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 17,382 characters.

### Executive Summary

PetMed Express was incorporated in the state of Florida in January 1996. The Company’s common stock is traded on the NASDAQ Global Select Market under the symbol “PETS.” The Company began selling pet medications and other pet health products in September 1996. In March 2010 the Company started offering for sale additional pet supplies on its website, and these items are drop shipped to customers by third party vendors. Presently, the Company’s product line includes approximately 3,000 SKUs of the most popular pet medications, health products, and supplies for dogs and cats.

The Company markets its products through national advertising campaigns which aim to increase the recognition of the “1-800-PetMeds” brand name, and “PetMeds” family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. Approximately 84% of all sales were generated via the Internet for the quarter ended June 30, 2017, compared to 82% for the quarter ended June 30, 2016. The Company’s sales consist of products sold mainly to retail consumers. The three-month average purchase was approximately $87 and $82 per order for the quarters ended on June 30, 2017 and 2016, respectively.

### Critical Accounting Policies

Our discussion and analysis of our financial condition and the results of our operations are based upon our Condensed Consolidated Financial Statements and the data used to prepare them. The Company’s Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America. On an ongoing basis we re-evaluate our judgments and estimates including those related to product returns, bad debts, inventories, and income taxes. We base our estimates and judgments on our historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. Actual results may differ from these estimates under different assumptions or conditions. Our estimates are guided by observing the following critical accounting policies.

Revenue recognition

The Company generates revenue by selling pet medications and pet supplies primarily to retail consumers. The Company’s policy is to recognize revenue from product sales upon shipment, when the rights of ownership and risk of loss have passed to the customer. Outbound shipping and handling fees are included in sales and are billed upon shipment. Shipping expenses are included in cost of sales. The majority of the Company’s sales are paid by credit cards and the Company usually receives the cash settlement in two to three banking days. Credit card sales minimize accounts receivable balances relative to sales.

The Company maintains an allowance for doubtful accounts for losses that the Company estimates will arise from customers’ inability to make required payments, arising from either credit card charge-backs or insufficient funds checks. The Company determines its estimates of the un-collectability of accounts receivable by analyzing historical bad debts and current economic trends. The allowance for doubtful accounts was approximately $31,000 at June 30, 2017, compared to $27,000 at March 31, 2017.

Valuation of inventory

Inventories consist of prescription and non-prescription pet medications and pet supplies that are available for sale and are priced at the lower of cost or net realizable value using a weighted average cost method. The Company writes down its inventory for estimated obsolescence. The inventory reserve was approximately $58,000 at June 30, 2017 compared to $51,000 at March 31, 2017.

Advertising

The Company's advertising expense consists primarily of Internet marketing and direct mail/print advertising. Internet costs are expensed in the month incurred and direct mail/print advertising costs are expensed when the related catalogs, brochures, and postcards are produced, distributed, or superseded.

Accounting for income taxes

The Company accounts for income taxes under the provisions of ASC Topic 740 (“*Accounting for Income Taxes”*), which generally requires recognition of deferred tax assets and liabilities for the expected future tax benefits or consequences of events that have been included in the Consolidated Financial Statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on differences between the financial reporting carrying values and the tax bases of assets and liabilities, and are measured by applying enacted tax rates and laws for the taxable years in which those differences are expected to reverse.

### Results of Operations

The following should be read in conjunction with the Company’s Condensed Consolidated Financial Statements and the related notes thereto included elsewhere herein. The following table sets forth, as a percentage of sales, certain operating data appearing in the Company’s Condensed Consolidated Statements of Comprehensive Income:

|  | Three Months Ended June 30, 2017 | 2016 |
| --- | ---: | ---: |
| Sales | 100.0% | 100.0% |
| Cost of sales | 65.5 | 69.0 |
| Gross profit | 34.5 | 31.0 |
| Operating expenses: |  |  |
| General and administrative | 7.8 | 8.4 |
| Advertising | 7.9 | 7.9 |
| Depreciation | 0.7 | 0.3 |
| Total operating expenses | 16.4 | 16.6 |
| Income from operations | 18.1 | 14.4 |
| Total other income | 0.4 | 0.1 |
| Income before provision for income taxes | 18.5 | 14.5 |
| Provision for income taxes | 6.9 | 5.4 |
| Net income | 11.6% | 9.1% |

9

### Three Months Ended June 30, 2017 Compared With Three Months Ended June 30, 2016

### Sales

Sales increased by approximately $7.2 million, or 9.9%, to approximately $79.7 million for the quarter ended June 30, 2017, from approximately $72.5 million for the quarter ended June 30, 2016. The increase in sales for the three months ended June 30, 2017 was primarily due to increased new order and reorder sales. The Company acquired approximately 169,000 new customers for the quarter ended June 30, 2017, compared to approximately 158,000 new customers for the same period the prior year. The following chart illustrates sales by various sales classifications:

*Three Months Ended June 30,*

|  |  |  |  |  |
| --- | ---: | ---: | ---: | ---: |
| **Sales (In thousands)** | **2017%** | **2016%** | **$ Variance** | **% Variance** |
| Reorder Sales | $64,465 80.9% | $59,166 81.6% | $5,299 | 9.0% |
| New Order Sales | $15,192 19.1% | $13,321 18.4% | $1,871 | 14.0% |
| Total Net Sales | $79,657 100.0% | $72,487 100.0% | $7,170 | 9.9% |
| Internet Sales | $66,647 83.7% | $59,350 81.9% | $7,297 | 12.3% |
| Contact Center Sales | $13,010 16.3% | $13,137 18.1% | $(127) | -1.0% |
| Total Net Sales | $79,657 100.0% | $72,487 100.0% | $7,170 | 9.9% |

Going forward sales may be adversely affected due to increased competition and consumers giving more consideration to price. No guarantees can be made that sales will continue to grow in the future. The majority of our product sales are affected by the seasons, due to the seasonality of mainly heartworm, and flea and tick medications. For the quarters ended June 30, September 30, December 31, and March 31 of Fiscal 2017, the Company’s sales were approximately 29%, 25%, 21%, and 25%, respectively.

### Cost of sales

Cost of sales increased by approximately $2.2 million, or 4.3%, to approximately $52.2 million for the quarter ended June 30, 2017, from approximately $50.0 million for the quarter ended June 30, 2016. The increase in cost of sales is directly related to the increase in sales during the quarter ended June 30, 2017. As a percent of sales, the cost of sales was 65.5% and 69.0% for the quarters ended June 30, 2017 and 2016, respectively. The cost of sales percentage decrease is mainly attributed to a product mix shift to higher margin items offset by additional discounts given to customers to increase sales during the quarter.

### Gross profit

Gross profit increased by approximately $5.0 million, or 22%, to approximately $27.5 million for the quarter ended June 30, 2017, from approximately $22.5 million for the quarter ended June 30, 2016. The increase in gross profit is directly related to the increase in sales during the quarter ended June 30, 2017. Gross profit as a percentage of sales was 34.5% and 31.0% for the quarters ended June 30, 2017 and 2016, respectively. The gross profit percentage increase is mainly attributed to a product mix shift to higher margin items offset by additional discounts given to customers to increase sales during the quarter.

### General and administrative expenses

General and administrative expenses increased by approximately $128,000, or 2.1%, to approximately $6.2 million for the quarter ended June 30, 2017, from approximately $6.1 million for the quarter ended June 30, 2016. The increase in general and administrative expenses for the three months ended June 30, 2017 was primarily due to the following: a $317,000 increase in payroll expenses related to increased stock compensation expense; a $156,000 increase in bank service fees; and a $65,000 increase in professional fees. Offsetting the increase was a $205,000 decrease to property expenses and a $205,000 decrease to bad debt expense relating to decreased credit card chargebacks for the period.

### Advertising expenses

Advertising expenses increased by approximately $532,000, or 9.2%, to approximately $6.3 million for the quarter ended June 30, 2017, from approximately $5.8 million for the quarter ended June 30, 2016. The increase in advertising expenses for the quarter was intended to stimulate sales and acquire new customers. The advertising costs of acquiring a new customer, defined as total advertising costs divided by new customers acquired, was $37 for both the quarters ended June 30, 2017 and 2016. Advertising cost of acquiring a new customer can be impacted by the advertising environment, the effectiveness of our advertising creative, advertising spending, and price competition. Historically, the advertising environment fluctuates due to supply and demand. A more favorable advertising environment may positively impact future new order sales, whereas a less favorable advertising environment may negatively impact future new order sales.

As a percentage of sales, advertising expense was 7.9% for both the quarters ended June 30, 2017 and 2016. The Company currently anticipates advertising as a percentage of sales to be between approximately 7.0% and 8.0% for fiscal 2018. However, the advertising percentage will fluctuate quarter to quarter due to seasonality and advertising availability.

### Depreciation

Depreciation expense increased by approximately $337,000, to approximately $531,000 for the quarter ended June 30, 2017, compared to approximately $194,000 for the quarter ended June 30, 2016. This increase to depreciation expense for the quarter ended June 30, 2017 can be attributed to an increase in new property and equipment additions related to the Company’s new corporate headquarters and distribution facility which were placed into service in fiscal 2017.

### Other income

Other income increased by approximately $243,000, to approximately $324,000 for the quarter ended June 30, 2017 compared to approximately $81,000 for the quarter ended June 30, 2016. The increase to other income for the quarter ended June 30, 2017 is related to increased rental and advertising revenue and increased interest income. Interest income may decrease in the future as the Company utilizes its cash balances on its share repurchase plan, with approximately $10.2 million remaining as of June 30, 2017, on any quarterly dividend payment, or on its operating activities.

### Provision for income taxes

For the quarters ended June 30, 2017 and 2016, the Company recorded an income tax provision of approximately $5.5 million and $3.9 million, respectively. The increase in the income tax provision for the quarter ended June 30, 2017 is related to an increase to operating income at June 30, 2017. The effective tax rate was approximately 37.1% for both the quarters ended June 30, 2017 and 2016. The Company adopted Accounting Standards Update on Stock Compensation Improvements to Employee Share-Based Payment Accounting (Topic 718) (ASU 2016-09) in fiscal 2017. ASU 2016-09 requires entities to recognize the income tax effects of share-based awards in the income statement when the awards vest or are settled. The impact of ASU 2016-09 may have a material effect on the Company’s effective tax rate in fiscal 2018, in the periods when restricted shares vest. Upon the vesting of restricted shares, if the value at vesting date exceeds the value at grant date, the effect will be a decrease to income taxes; conversely if the value at vesting date is less than the value at grant date, the effect will be an increase to income taxes. The impact of ASU 2016-09 may be material to the results of operations in future periods depending upon, among other things, the level of earnings and stock price of the Company.

### Liquidity and Capital Resources

The Company’s working capital at June 30, 2017 and March 31, 2017 was $69.5 million and $63.4 million, respectively. The $6.1 million increase in working capital was primarily attributable to cash flow generated from operations, offset by dividends paid. Net cash provided by operating activities was $13.9 million and $13.1 million for the three months ended June 30, 2017 and 2016, respectively. This increase is mainly attributed to an increase in net income offset by a net decrease in operating activities for the quarter ended June 30, 2017, compared to the quarter ended June 30, 2016. Net cash used in investing activities decreased to $43,000 for the three months ended June 30, 2017, compared to $2.6 million used in investing activities for the three months ended June 30, 2016. This change in investing activities is related to increased property additions related to the Company’s new corporate headquarters and distribution facility in Delray Beach, Florida in the previous fiscal year. Net cash used in financing activities was $4.1 million for the quarter ended June 30, 2017 compared to $3.8 million for the quarter ended June 30, 2016, which represented an increase in the dividend paid in the quarter ended June 30, 2017.

At June 30, 2017 the Company had approximately $10.2 million remaining under the Company’s share repurchase plan. On July 24, 2017 our Board of Directors declared a $0.20 per share dividend. The Board established an August 7, 2017 record date and an August 18, 2017 payment date. Depending on future market conditions the Company may utilize its cash and cash equivalents on the remaining balance of its current share repurchase plan, on quarterly dividends, or on its operating activities.

At June 30, 2017 the Company had no outstanding lease commitments, and as of June 30, 2016 the Company had no outstanding lease commitments except for the lease for its 65,300 square foot facility in Pompano Beach, Florida. We are not currently bound by any long or short term agreements for the purchase or lease of capital expenditures. Any material amounts expended for capital expenditures would be the result of an increase in the capacity needed to adequately provide for any increase in our business. To date we have paid for any needed additions to our capital equipment infrastructure from working capital funds and anticipate this being the case in the future. Presently, we have approximately $1.0 million forecasted for capital expenditures for the remainder of fiscal 2018, which will be funded through cash from operations. The Company’s primary source of working capital is cash from operations. The Company presently has no need for alternative sources of working capital, and has no commitments or plans to obtain additional capital.

### Off-Balance Sheet Arrangements

The Company had no off-balance sheet arrangements at June 30, 2017.

### Cautionary Statement Regarding Forward-Looking Information

Certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You can identify these forward-looking statements by the words "believes," "intends," "expects," "may," "will," "should," "plans," "projects," "contemplates," "intends," "budgets," "predicts," "estimates," "anticipates," or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions. Actual future results may differ significantly from the results discussed in the forward-looking statements. A reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements, which apply only as of the date of this quarterly report. When used in this quarterly report on Form 10-Q, "PetMed Express," "1-800-PetMeds," "PetMeds," "PetMed," "PetMeds.com," "PetMed.com," "PetMed Express.com," "the Company," "we," "our," and "us" refers to PetMed Express, Inc. and our subsidiaries.

## Market risk

As filed, 1,579 characters.

Market risk generally represents the risk that losses may occur in the value of financial instruments as a result of movements in interest rates, foreign currency exchange rates, and commodity prices. Our financial instruments include cash and cash equivalents, short term investments, accounts receivable, and accounts payable. The book values of cash equivalents, short term investments, accounts receivable, and accounts payable are considered to be representative of fair value because of the short maturity of these instruments. Interest rates affect our return on excess cash and investments. At June 30, 2017, we had $68.5 million in cash and cash equivalents, and the majority of our cash and cash equivalents and investments generate interest income based on prevailing interest rates. A significant change in interest rates would impact the amount of interest income generated from our excess cash and investments. It would also impact the market value of our short term investments. Our investments are subject to market risk, primarily interest rate and credit risk. Our investments are managed by a limited number of outside professional managers within investment guidelines set by our Board of Directors. Such guidelines include security type, credit quality, and maturity, and are intended to limit market risk by restricting our investments to high-quality debt instruments with both short and long term maturities. We do not hold any derivative financial instruments that could expose us to significant market risk. At June 30, 2017, we had no debt obligations.

## Controls and procedures

As filed, 1,363 characters.

The Company’s management, including our Chief Executive Officer and Chief Financial Officer, has conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15 promulgated under the Securities Exchange Act of 1934, as amended) as of the quarter ended June 30, 2017, the end of the period covered by this report (the "Evaluation Date"). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective such that the information relating to our Company, including our consolidated subsidiaries, required to be disclosed by the Company in reports that it files or submits under the Exchange Act: (1) is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and (2) is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 406 characters.

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition, results of operations, and trading price of our common stock. Please refer to our Annual Report on Form 10-K for the fiscal year ended March 31, 2017 for additional information concerning these and other uncertainties that could negatively impact the Company.

Filed Jul 31, 2017.
Source: SEC EDGAR, the filing index for accession 0001437749-17-013354. Last ingested by Listed: Nov 13, 2026, 14:26 ET. No prices; not investment advice.
